Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Teligent
  6. News
  7. Summary
    TLGT   US87960W2035

TELIGENT

(TLGT)
Delayed OTC Markets  -  09:30 2022-07-27 am EDT
0.000200 USD   -.--%
08/05Hikma's diversified business delivers resilient H1 performance
AQ
07/26Teligent, Inc. Went Out of Business
CI
07/15Second Amended Liquidation Plan Approved for Teligent, Inc.
CI
SummaryQuotesChartsNewsRatingsCompanyFunds 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds
Most relevant news about TELIGENT
07/26Teligent, Inc. Went Out of Business
CI
07/15Second Amended Liquidation Plan Approved for Teligent, Inc.
CI
05/25Second Motion for Exclusivity Period Extension Approved For Teligent, Inc.
CI
05/24Second Amended Joint Liquidation Plan Filed by Teligent, Inc.
CI
04/29First Amended Disclosure Statement Approved for Teligent, Inc.
CI
04/27First Amended Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc.
CI
04/08Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc.
CI
02/28First Motion for Exclusivity Period Extension Approved For Teligent, Inc.
CI
02/22Motion for Case Conversion Filed by Teligent, Inc.
CI
02/09First Motion for Exclusivity Period Extension Filed by Teligent, Inc.
CI
02/03Pharmaceutical Associates, Inc. completed the acqui..
CI
02/03Hikma Pharmaceuticals PLC completed the acquisition..
CI
01/19Motion for Asset Sale Approved for Teligent, Inc.
CI
01/19Motion for Asset Sale Approved for Teligent, Inc.
CI
01/18Motion for Asset Sale Approved for Teligent, Inc.
CI
More most relevant news
All news about TELIGENT
08/05Hikma's diversified business delivers resilient H1 performance
AQ
07/26Teligent, Inc. Went Out of Business
CI
07/15Second Amended Liquidation Plan Approved for Teligent, Inc.
CI
05/25Second Motion for Exclusivity Period Extension Approved For Teligent, Inc.
CI
05/24Second Amended Joint Liquidation Plan Filed by Teligent, Inc.
CI
04/29First Amended Disclosure Statement Approved for Teligent, Inc.
CI
04/27First Amended Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc.
CI
04/08Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc.
CI
02/28First Motion for Exclusivity Period Extension Approved For Teligent, Inc.
CI
02/22Motion for Case Conversion Filed by Teligent, Inc.
CI
More news
News in other languages on TELIGENT
07/26Teligent, Inc. a fait faillite
05/25Deuxième motion pour la prolongation de la période d'exclusivité approuvée pour Teligen..
04/29Première déclaration de divulgation amendée approuvée pour Teligent, Inc.
02/28La première demande de prolongation de la période d'exclusivité est approuvée pour Teli..
02/22Requête en conversion de cas déposée par Teligent, Inc.
02/09Première requête de prolongation de la période d'exclusivité déposée par Teligent, Inc.
02/03Hikma Pharmaceuticals conclut l'achat de 46 millions de dollars des actifs canadiens de..
02/03Pharmaceutical Associates, Inc. a finalisé l'acquis..
02/03Hikma Pharmaceuticals PLC (LSE:HIK) a finalisé l'acquisit..
01/17Hikma Pharmaceuticals entre sur le marché canadien grâce à une acquisition d'actifs de ..
More news
Press releases
08/05Hikma's diversified business delivers resilient H1 performance
AQ
01/18Hikma expands into Canada with acquisition of Teligent sterile injectable assets
AQ
2021What We're Reading This Week
AQ
2021Teligent : Company is arranging $12 million debtor-in-possession financing from its senior..
PU
2021Teligent, Inc. : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, C..
AQ
More press releases